LEVOTHYROXINE sodium, 0.025mg, tab.

STD DORALEVO2T-

Valid Article

Former Code(s): DORAZBD0339 DORAZNL0316 DORAZYN1040 DORAOCBZLB0022
18.7 - Thyroid hormones and antithyroid medicines
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
H03AA01
Anatomical Therapeutic Chemical Classification according to WHOCC
The order of this product needs to be justified and is only acceptable under certain conditions.
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

Add article to list

   

Add Kit To Wishlist

   

LEVOTHYROXINE

Therapeutic Action

Thyroid hormone

Indications

Hypothyroidism and hyperthyroidism

Some restricted information has been hidden. Sign in to see this information

Instructions for use

0.025 mg is equivalent to 25 µg levothyroxine.

0.1 mg is equivalent to 100 µg levothyroxine.

The 0.025 mg tablet is used for gradual dose escalation in adults < 60 years of age and for the initial dose in adults ≥ 60 years of age.

The total daily dose should be taken in the morning on an empty stomach and at least 30 min before breakfast.

Storage

Below 25°C